OPAS

Introducing OPAS, our cross-platform application that revolutionizes access to up-to-date pharmaceutical information for medical professionals. As the first mobile solution of its kind, OPAS provides direct access to pharmaceutical information leaflets and patient materials, designed by pharmaceutical companies.

Typically, such leaflets provide crucial up-to-date information on new medicine dosage details, indications, prior authorization requirements, prizing and plenty of patient materials such as video instructions for patients.

With OPAS, you can access material from various pharmaceutical companies within a single application. No need to sign-in to multiple different web-portals.

Accessing the material requires a FimNet account.

OUR COMPANY

Epiomed was founded to fill an avenue in pharmaceutical business benefiting from digitalisation and streamlining of everyday work flow of pharmaceutical professionals and medical doctors.

As a result, we started to collaborate with various key players in pharmaceutical business to develop the OPAS platform in 2022. Now, we are in a pilot testing phase and aim to launch the platform in 2023.

SERVICES

CONTACT